- Recently-listed healthcare services provider Uniphar swung to a first-half profit, driven by sales growth at its marketing services and medicine sourcing divisions.

Pre-tax profit for the six months through June amounted to €11.6m, compared to a loss of €0.8m on-year.

Revenue rose 20% to €800.1m and adjusted profit more than doubled to €13.8m, up from €5.0m.

'Our results reflect a very strong performance for the first six months of 2019 which is in line with board expectations, and positions us to deliver our full year 2019 plan,' chief executive Ger Rabbette said.

'Our product access and commercial & clinical divisions continue to be the key growth engines for the group particularly in the UK and Benelux markets, while supply chain & retail saw strong volume growth in Ireland.'

Rabbette said that Uniphar, which completed an IPO in July, was 'on a firm footing for the second half of the year, going into 2020, and the next stage of our planned development in delivering our five year strategy'.

At 1:27pm: [LON:UPR] share price was +0.03p at 1.15p

Story provided by